⚠ Breakingviews.com requires the use of cookies. Please enable cookies in your browser settings.
Sign In Request a Free Trial

|

Request a Free Trial
Browse by Topic
Sign In
Home Regions Columns Features Videos Podcasts Books Calculators Ukraine/Russia Contact Us
Americas EMEA Asia

Nestlé bets biggest in brand giants’ tariff casino

15 May 2025

US Congress will be reluctant trade war spoiler

14 May 2025

Apple’s China detox is painful and overdue

13 May 2025

Private credit’s mass appeal creates new risks

12 May 2025

Tech can give Europe more bang for defence buck

8 May 2025

US exceptionalism becoming a matter of perspective

8 May 2025

Donald Trump may help Ukraine despite himself

6 May 2025

Gold’s golden moment dazzles better-value rivals

2 May 2025

Trump’s low pain threshold limits economic damage

28 Apr 2025

Europe can take advantage of King Dollar’s wobble

24 Apr 2025

Pauses, tweaks and can-kicking are new trade norms

15 May 2025

Europe’s self-defence is battle on multiple fronts

13 May 2025

Buffett’s $350 bln parting gift is double-edged

8 May 2025

Why US-China decoupling will be hard to reverse

6 May 2025

CK Hutchison deal is test of Chinese hospitality

1 May 2025

This website uses cookies to ensure you get the best experience on our website. Learn more
Got it!

Healthcare

US hostile deal offers arb opportunity

28 May 2004

At first glance, Omnicare looks like it will struggle to clinch the $1.3bn takeover of rival Neighborcare. But look again, the omens and both firms' rising stock prices suggest there is a deal to be done and money to be made.

Nestle slightly loosens L’Oreal impasse

4 Feb 2004

Nestle now has a direct stake in L Oreal, rather than a minority position in the parent and no longer risks having to buy the whole group. But the only way something could move in the shortterm is if there was a bid for L Oreal. And that doesn t look terribly likely.

Smith & Nephew offers £1.5bn for Centerpulse

20 Mar 2003

There is strategic logic to combining the orthopaedics groups. They need scale economies to fund research and development. The tiny premium offered may suggest the UK group has got a bargain. A returns analysis suggests otherwise.

The time may be ripe for a takeover of Centerpulse, says David Reilly.

15 Nov 2002

Heard in Europe: Nobel Biocare’s hopes for stock price bolster

7 Oct 2002

Heard in Europe: Smith & Nephew nixes hopes for merger

2 Aug 2002

Uppity barbarians

18 Jul 2002

Heard in Europe: Bloodletting at Centerpulse

17 Jul 2002

Drugs rush

7 Aug 2000

Posts pagination

Previous page Page 1 … Page 56 Page 57
 

Most Popular

  • Gulf’s delicate US-China balance can easily flip
  • Foot Locker deal calls for some fancy footwork
  • US Congress will be reluctant trade war spoiler
  • Value investing is poised to rise from the dead
  • Walmart can discount tariffs only so much
 

Thomson Reuters Products

Westlaw
Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology.
Onesource
The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs.
Checkpoint
The industry leader for online information for tax, accounting and finance professionals.

LSEG Products

Workspace
Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile.
Data Catalogue
Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts.
World-Check
Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks.

  • Browse by Topic
  • About Us
  • Journalists
  • Jobs
  • Contact Us
  • Tips and Tricks
  • Mobile App
  • Privacy
  • Terms of Use
© Reuters News & Media Ltd 2025. All rights reserved.